Loading company…
Pittsburgh clinical-stage biotech founded in 2013 that develops engineered peptide therapeutics for life-threatening infections.
Founded in 2013 and based in Pittsburgh, US, Peptilogics, Inc. is a clinical-stage biotechnology company developing engineered peptide therapeutics against life-threatening infections, including prosthetic joint infections and lung infections related to cystic fibrosis. It uses a proprietary AI-driven discovery platform. The company is at Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in